Back

Interplay between intrinsic reprogramming potential and microenvironment controls neuroblastoma cell plasticity and identity

Thirant, C.; Peltier, A.; Durand, S.; Kramdi, A.; Louis-Brennetot, C.; Pierre-Eugene, C.; Costa, A.; Grelier, A.; Zaidi, S.; Gruel, N.; Jimenez, I.; Lapouble, E.; Pierron, G.; Brisse, H.; Gauthier, A.; Freneaux, P.; Grossetete-Lalami, S.; Baudrin, L. G.; Raynal, V.; Baulande, S.; Bellini, A.; Bhalshankar, J.; Carcaboso, A. M.; Geoerger, B.; Surdez, D.; Rohrer, H.; Boeva, V.; Schleiermacher, G.; Delattre, O.; Janoueix-Lerosey, I.

2021-01-08 cancer biology
10.1101/2021.01.07.425710 bioRxiv
Show abstract

Two cell identities, noradrenergic and mesenchymal, have been characterized in neuroblastoma cell lines according to their epigenetic landscapes relying on specific circuitries of transcription factors. Yet, their relationship and relative contribution in patient tumors remain poorly defined. Here, we demonstrate that the knock-out of GATA3, but not of PHOX2A or PHOX2B, in noradrenergic cells induces a mesenchymal phenotype. Our results document spontaneous plasticity in several models between both identities and show that plasticity relies on epigenetic reprogramming. We demonstrate that an in vivo microenvironment provides a powerful pressure towards a noradrenergic identity for these models. Consistently, tumor cells with a mesenchymal identity are not detected in a series of PDX models. Further study of the intra-tumor noradrenergic heterogeneity reveals two distinct cell populations exhibiting features of chromaffin-like or sympathoblast-like cells. This work emphasizes that both external cues of the environment and intrinsic factors control plasticity and cell identity in neuroblastoma.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 17%
10.6%
2
eLife
5828 papers in training set
Top 13%
7.8%
3
Cell Reports
1498 papers in training set
Top 4%
7.2%
4
Scientific Reports
3612 papers in training set
Top 16%
5.5%
5
Neuro-Oncology
36 papers in training set
Top 0.2%
5.5%
6
Molecular Cancer
16 papers in training set
Top 0.1%
4.8%
7
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.1%
4.3%
8
Communications Biology
993 papers in training set
Top 4%
4.0%
9
iScience
1154 papers in training set
Top 5%
3.5%
50% of probability mass above
10
Science Advances
1243 papers in training set
Top 9%
3.5%
11
Neoplasia
23 papers in training set
Top 0.2%
2.4%
12
Cells
249 papers in training set
Top 2%
2.4%
13
Cell Death & Disease
126 papers in training set
Top 1%
2.1%
14
Cancers
213 papers in training set
Top 3%
1.9%
15
Oncogene
85 papers in training set
Top 1%
1.5%
16
International Journal of Cancer
49 papers in training set
Top 0.9%
1.1%
17
Cancer Research
130 papers in training set
Top 2%
1.1%
18
Cell Death Discovery
58 papers in training set
Top 1.0%
1.1%
19
Stem Cell Reports
130 papers in training set
Top 2%
1.0%
20
Oncogenesis
12 papers in training set
Top 0.2%
1.0%
21
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 39%
0.9%
22
Cellular and Molecular Life Sciences
96 papers in training set
Top 2%
0.8%
23
Cancer Research Communications
51 papers in training set
Top 2%
0.8%
24
Cell Reports Medicine
153 papers in training set
Top 5%
0.8%
25
Clinical Cancer Research
64 papers in training set
Top 2%
0.8%
26
EMBO Molecular Medicine
95 papers in training set
Top 3%
0.8%
27
Molecular Oncology
55 papers in training set
Top 1%
0.8%
28
Cell Communication and Signaling
51 papers in training set
Top 2%
0.6%